FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to pharmaceutical compositions of iron (III) citrate in form of a tablet, methods of using said compositions for preventing or treating hyperphosphatemia or serum phosphorus control and methods of producing said compositions.
EFFECT: medicinal forms of iron (III) citrate are offered.
28 cl, 35 tbl, 13 ex, 9 dwg
Authors
Dates
2020-10-01—Published
2010-07-21—Filed